IBDEI088 ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10811,2)
 ;;=^7839
 ;;^UTILITY(U,$J,358.3,10812,0)
 ;;=367.20^^72^697^7
 ;;^UTILITY(U,$J,358.3,10812,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10812,1,3,0)
 ;;=3^Astigmatism,NOS
 ;;^UTILITY(U,$J,358.3,10812,1,4,0)
 ;;=4^367.20
 ;;^UTILITY(U,$J,358.3,10812,2)
 ;;=^11141
 ;;^UTILITY(U,$J,358.3,10813,0)
 ;;=367.0^^72^697^31
 ;;^UTILITY(U,$J,358.3,10813,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10813,1,3,0)
 ;;=3^Hypermetropia
 ;;^UTILITY(U,$J,358.3,10813,1,4,0)
 ;;=4^367.0
 ;;^UTILITY(U,$J,358.3,10813,2)
 ;;=^60139
 ;;^UTILITY(U,$J,358.3,10814,0)
 ;;=367.1^^72^697^36
 ;;^UTILITY(U,$J,358.3,10814,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10814,1,3,0)
 ;;=3^Myopia
 ;;^UTILITY(U,$J,358.3,10814,1,4,0)
 ;;=4^367.1
 ;;^UTILITY(U,$J,358.3,10814,2)
 ;;=^80671
 ;;^UTILITY(U,$J,358.3,10815,0)
 ;;=V43.1^^72^697^44
 ;;^UTILITY(U,$J,358.3,10815,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10815,1,3,0)
 ;;=3^Pseudophakia
 ;;^UTILITY(U,$J,358.3,10815,1,4,0)
 ;;=4^V43.1
 ;;^UTILITY(U,$J,358.3,10815,2)
 ;;=^69114
 ;;^UTILITY(U,$J,358.3,10816,0)
 ;;=367.9^^72^697^46
 ;;^UTILITY(U,$J,358.3,10816,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10816,1,3,0)
 ;;=3^Refractive Error
 ;;^UTILITY(U,$J,358.3,10816,1,4,0)
 ;;=4^367.9
 ;;^UTILITY(U,$J,358.3,10816,2)
 ;;=^35634
 ;;^UTILITY(U,$J,358.3,10817,0)
 ;;=365.04^^72^697^26
 ;;^UTILITY(U,$J,358.3,10817,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10817,1,3,0)
 ;;=3^Glaucoma Ocular Hypertension
 ;;^UTILITY(U,$J,358.3,10817,1,4,0)
 ;;=4^365.04
 ;;^UTILITY(U,$J,358.3,10817,2)
 ;;=^85124
 ;;^UTILITY(U,$J,358.3,10818,0)
 ;;=365.01^^72^697^30
 ;;^UTILITY(U,$J,358.3,10818,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10818,1,3,0)
 ;;=3^Glaucoma Suspect
 ;;^UTILITY(U,$J,358.3,10818,1,4,0)
 ;;=4^365.01
 ;;^UTILITY(U,$J,358.3,10818,2)
 ;;=^340633
 ;;^UTILITY(U,$J,358.3,10819,0)
 ;;=365.71^^72^697^24
 ;;^UTILITY(U,$J,358.3,10819,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10819,1,3,0)
 ;;=3^Glaucoma Mild Stage
 ;;^UTILITY(U,$J,358.3,10819,1,4,0)
 ;;=4^365.71
 ;;^UTILITY(U,$J,358.3,10819,2)
 ;;=^340513
 ;;^UTILITY(U,$J,358.3,10820,0)
 ;;=365.72^^72^697^25
 ;;^UTILITY(U,$J,358.3,10820,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10820,1,3,0)
 ;;=3^Glaucoma Moderate Stage
 ;;^UTILITY(U,$J,358.3,10820,1,4,0)
 ;;=4^365.72
 ;;^UTILITY(U,$J,358.3,10820,2)
 ;;=^340514
 ;;^UTILITY(U,$J,358.3,10821,0)
 ;;=365.73^^72^697^28
 ;;^UTILITY(U,$J,358.3,10821,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10821,1,3,0)
 ;;=3^Glaucoma Severe Stage
 ;;^UTILITY(U,$J,358.3,10821,1,4,0)
 ;;=4^365.73
 ;;^UTILITY(U,$J,358.3,10821,2)
 ;;=^340515
 ;;^UTILITY(U,$J,358.3,10822,0)
 ;;=362.51^^72^697^1
 ;;^UTILITY(U,$J,358.3,10822,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10822,1,3,0)
 ;;=3^AMD,Dry
 ;;^UTILITY(U,$J,358.3,10822,1,4,0)
 ;;=4^362.51
 ;;^UTILITY(U,$J,358.3,10822,2)
 ;;=^268636
 ;;^UTILITY(U,$J,358.3,10823,0)
 ;;=362.52^^72^697^2
 ;;^UTILITY(U,$J,358.3,10823,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10823,1,3,0)
 ;;=3^AMD,Wet/Exudative
 ;;^UTILITY(U,$J,358.3,10823,1,4,0)
 ;;=4^362.52
 ;;^UTILITY(U,$J,358.3,10823,2)
 ;;=^268637
 ;;^UTILITY(U,$J,358.3,10824,0)
 ;;=362.04^^72^697^14
 ;;^UTILITY(U,$J,358.3,10824,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10824,1,3,0)
 ;;=3^DM Mild NPDR
 ;;^UTILITY(U,$J,358.3,10824,1,4,0)
 ;;=4^362.04
 ;;^UTILITY(U,$J,358.3,10824,2)
 ;;=^332787
 ;;^UTILITY(U,$J,358.3,10825,0)
 ;;=362.05^^72^697^15
 ;;^UTILITY(U,$J,358.3,10825,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10825,1,3,0)
 ;;=3^DM Moderate NPDR
 ;;^UTILITY(U,$J,358.3,10825,1,4,0)
 ;;=4^362.05
 ;;^UTILITY(U,$J,358.3,10825,2)
 ;;=^332788
 ;;^UTILITY(U,$J,358.3,10826,0)
 ;;=362.06^^72^697^17
 ;;^UTILITY(U,$J,358.3,10826,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10826,1,3,0)
 ;;=3^DM Severe NPDR
 ;;^UTILITY(U,$J,358.3,10826,1,4,0)
 ;;=4^362.06
 ;;^UTILITY(U,$J,358.3,10826,2)
 ;;=^332789
 ;;^UTILITY(U,$J,358.3,10827,0)
 ;;=362.02^^72^697^16
 ;;^UTILITY(U,$J,358.3,10827,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10827,1,3,0)
 ;;=3^DM PDR
 ;;^UTILITY(U,$J,358.3,10827,1,4,0)
 ;;=4^362.02
 ;;^UTILITY(U,$J,358.3,10827,2)
 ;;=^268610
 ;;^UTILITY(U,$J,358.3,10828,0)
 ;;=379.39^^72^697^45
 ;;^UTILITY(U,$J,358.3,10828,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10828,1,3,0)
 ;;=3^Pseudophakia
 ;;^UTILITY(U,$J,358.3,10828,1,4,0)
 ;;=4^379.39
 ;;^UTILITY(U,$J,358.3,10828,2)
 ;;=^87515
 ;;^UTILITY(U,$J,358.3,10829,0)
 ;;=367.9^^72^697^18
 ;;^UTILITY(U,$J,358.3,10829,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10829,1,3,0)
 ;;=3^Disorder of Refraction
 ;;^UTILITY(U,$J,358.3,10829,1,4,0)
 ;;=4^367.9
 ;;^UTILITY(U,$J,358.3,10829,2)
 ;;=^35634
 ;;^UTILITY(U,$J,358.3,10830,0)
 ;;=373.2^^72^697^35
 ;;^UTILITY(U,$J,358.3,10830,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10830,1,3,0)
 ;;=3^Meibomianitis
 ;;^UTILITY(U,$J,358.3,10830,1,4,0)
 ;;=4^373.2
 ;;^UTILITY(U,$J,358.3,10830,2)
 ;;=^22156
 ;;^UTILITY(U,$J,358.3,10831,0)
 ;;=V58.69^^72^697^33
 ;;^UTILITY(U,$J,358.3,10831,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10831,1,3,0)
 ;;=3^Long Term Use of Medication
 ;;^UTILITY(U,$J,358.3,10831,1,4,0)
 ;;=4^V58.69
 ;;^UTILITY(U,$J,358.3,10831,2)
 ;;=^303460
 ;;^UTILITY(U,$J,358.3,10832,0)
 ;;=379.24^^72^697^51
 ;;^UTILITY(U,$J,358.3,10832,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10832,1,3,0)
 ;;=3^Vitreous Floaters
 ;;^UTILITY(U,$J,358.3,10832,1,4,0)
 ;;=4^379.24
 ;;^UTILITY(U,$J,358.3,10832,2)
 ;;=^88242
 ;;^UTILITY(U,$J,358.3,10833,0)
 ;;=V80.2^^72^697^47
 ;;^UTILITY(U,$J,358.3,10833,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10833,1,3,0)
 ;;=3^Screening for Eye Condition
 ;;^UTILITY(U,$J,358.3,10833,1,4,0)
 ;;=4^V80.2
 ;;^UTILITY(U,$J,358.3,10833,2)
 ;;=^295685
 ;;^UTILITY(U,$J,358.3,10834,0)
 ;;=V70.5^^72^697^48
 ;;^UTILITY(U,$J,358.3,10834,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10834,1,3,0)
 ;;=3^Screening,Occupational
 ;;^UTILITY(U,$J,358.3,10834,1,4,0)
 ;;=4^V70.5
 ;;^UTILITY(U,$J,358.3,10834,2)
 ;;=^295595
 ;;^UTILITY(U,$J,358.3,10835,0)
 ;;=365.11^^72^697^27
 ;;^UTILITY(U,$J,358.3,10835,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10835,1,3,0)
 ;;=3^Glaucoma Primary Open Angle
 ;;^UTILITY(U,$J,358.3,10835,1,4,0)
 ;;=4^365.11
 ;;^UTILITY(U,$J,358.3,10835,2)
 ;;=^51203
 ;;^UTILITY(U,$J,358.3,10836,0)
 ;;=365.70^^72^697^29
 ;;^UTILITY(U,$J,358.3,10836,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10836,1,3,0)
 ;;=3^Glaucoma Stage NOS
 ;;^UTILITY(U,$J,358.3,10836,1,4,0)
 ;;=4^365.70
 ;;^UTILITY(U,$J,358.3,10836,2)
 ;;=^340609
 ;;^UTILITY(U,$J,358.3,10837,0)
 ;;=365.74^^72^697^23
 ;;^UTILITY(U,$J,358.3,10837,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10837,1,3,0)
 ;;=3^Glaucoma Indeterminate Stage
 ;;^UTILITY(U,$J,358.3,10837,1,4,0)
 ;;=4^365.74
 ;;^UTILITY(U,$J,358.3,10837,2)
 ;;=^340516
 ;;^UTILITY(U,$J,358.3,10838,0)
 ;;=373.32^^73^698^48
 ;;^UTILITY(U,$J,358.3,10838,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10838,1,3,0)
 ;;=3^Eyelid,Dermatitis,Allergic
 ;;^UTILITY(U,$J,358.3,10838,1,4,0)
 ;;=4^373.32
 ;;^UTILITY(U,$J,358.3,10838,2)
 ;;=^269061
 ;;^UTILITY(U,$J,358.3,10839,0)
 ;;=373.00^^73^698^4
 ;;^UTILITY(U,$J,358.3,10839,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10839,1,3,0)
 ;;=3^Blepharitis
 ;;^UTILITY(U,$J,358.3,10839,1,4,0)
 ;;=4^373.00
 ;;^UTILITY(U,$J,358.3,10839,2)
 ;;=Blepharitis^15271
 ;;^UTILITY(U,$J,358.3,10840,0)
 ;;=373.2^^73^698^7
 ;;^UTILITY(U,$J,358.3,10840,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10840,1,3,0)
 ;;=3^Chalazion
 ;;^UTILITY(U,$J,358.3,10840,1,4,0)
 ;;=4^373.2
 ;;^UTILITY(U,$J,358.3,10840,2)
 ;;=^22156
 ;;^UTILITY(U,$J,358.3,10841,0)
 ;;=374.84^^73^698^29
 ;;^UTILITY(U,$J,358.3,10841,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10841,1,3,0)
 ;;=3^Eyelid Cysts
 ;;^UTILITY(U,$J,358.3,10841,1,4,0)
 ;;=4^374.84
 ;;^UTILITY(U,$J,358.3,10841,2)
 ;;=^269119
 ;;^UTILITY(U,$J,358.3,10842,0)
 ;;=374.87^^73^698^31
 ;;^UTILITY(U,$J,358.3,10842,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10842,1,3,0)
 ;;=3^Eyelid Dermatochalasis
 ;;^UTILITY(U,$J,358.3,10842,1,4,0)
 ;;=4^374.87
 ;;^UTILITY(U,$J,358.3,10842,2)
 ;;=^269123
 ;;^UTILITY(U,$J,358.3,10843,0)
 ;;=375.15^^73^698^12
 ;;^UTILITY(U,$J,358.3,10843,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10843,1,3,0)
 ;;=3^Dry Eye Syndrome
 ;;^UTILITY(U,$J,358.3,10843,1,4,0)
 ;;=4^375.15
 ;;^UTILITY(U,$J,358.3,10843,2)
 ;;=Dry Eye Syndrome^37168
 ;;^UTILITY(U,$J,358.3,10844,0)
 ;;=374.01^^73^698^20
 ;;^UTILITY(U,$J,358.3,10844,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10844,1,3,0)
 ;;=3^Entropion, Senile
 ;;^UTILITY(U,$J,358.3,10844,1,4,0)
 ;;=4^374.01
 ;;^UTILITY(U,$J,358.3,10844,2)
 ;;=Entropion, Senile^269074
 ;;^UTILITY(U,$J,358.3,10845,0)
 ;;=375.20^^73^698^68
 ;;^UTILITY(U,$J,358.3,10845,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10845,1,3,0)
 ;;=3^Lacrimal,Epiphora
 ;;^UTILITY(U,$J,358.3,10845,1,4,0)
 ;;=4^375.20
 ;;^UTILITY(U,$J,358.3,10845,2)
 ;;=Epiphora^269136
 ;;^UTILITY(U,$J,358.3,10846,0)
 ;;=373.11^^73^698^63
 ;;^UTILITY(U,$J,358.3,10846,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10846,1,3,0)
 ;;=3^Hordeolum Externum
 ;;^UTILITY(U,$J,358.3,10846,1,4,0)
 ;;=4^373.11
 ;;^UTILITY(U,$J,358.3,10846,2)
 ;;=^58510
 ;;^UTILITY(U,$J,358.3,10847,0)
 ;;=373.12^^73^698^64
 ;;^UTILITY(U,$J,358.3,10847,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10847,1,3,0)
 ;;=3^Hordeolum Internum
 ;;^UTILITY(U,$J,358.3,10847,1,4,0)
 ;;=4^373.12
 ;;^UTILITY(U,$J,358.3,10847,2)
 ;;=^58512
 ;;^UTILITY(U,$J,358.3,10848,0)
 ;;=216.1^^73^698^54
 ;;^UTILITY(U,$J,358.3,10848,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10848,1,3,0)
 ;;=3^Eyelid/Canthus,Benign Neopl
 ;;^UTILITY(U,$J,358.3,10848,1,4,0)
 ;;=4^216.1
 ;;^UTILITY(U,$J,358.3,10848,2)
 ;;=Neoplasm, Benign of Lid^267630
 ;;^UTILITY(U,$J,358.3,10849,0)
 ;;=374.30^^73^698^43
 ;;^UTILITY(U,$J,358.3,10849,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10849,1,3,0)
 ;;=3^Eyelid Ptosis,Unspec
